Chandigarh – In a landmark move to reshape public healthcare access, Punjab Chief Minister Bhagwant Mann…
Continue ReadingCategory: Policy & Regulations
Insights on CDSCO, DCGI guidelines, drug approval laws, pricing control, and government policies impacting the Indian pharma industry.
NITI Aayog Pushes for Pharma Quality Overhaul as Industry Flags Regulatory and Pricing Roadblocks
New Delhi – In a decisive move to elevate India’s pharmaceutical manufacturing standards, NITI Aayog recently…
Continue Reading
AstraZeneca India Gets CDSCO Green Light for New Use of Osimertinib in Advanced EGFR-Mutated Lung Cancer
In a major stride for lung cancer treatment in India, AstraZeneca India Pharma has secured approval…
Continue Reading
Lupin Secures Tentative US FDA Nod for Generic Oxcarbazepine ER Tablets
In a significant boost to its U.S. generics portfolio, global pharmaceutical company Lupin has received tentative…
Continue Reading